A STUDY ON RISK FACTORS AND COMPLICATIONS OF POLYCYSTIC OVARIAN SYNDROME (PCOS)
Main Article Content
Keywords
PCOS, Polycystic ovary syndrome, hirsutism, infertility, acne, risk factors, menstrual irregularities.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age, involving pathways that produce metabolic, reproductive, cardiovascular and dermatologic effects. As per 2003 Rotterdam criteria, the symptoms like oligo-or anovulation, hyper-androgenism, polycystic ovarian morphology on transvaginal ultrasonography are used establish a definitive diagnosis. The exact cause is still unknown and may be caused by genetic, hormonal, and environmental factors. In this present observational study, we have evaluated the risk factors and associated complications in patients of PCOS in a tertiary care hospital in Karimnagar, Telangana. A total of 103 female PCOS patients were enrolled for duration of 6 months by following inclusion and exclusion criteria of the study after seeking their consent. The study results revealed that most of the females of the 21-30 age group, with 52%, were diagnosed with PCOS. Most of the patients reported abnormalities in lifestyle factors such as 66% of physical inactivity, 34.9% of inadequate sleep, 55.3% of stress, and 58.2% of unhealthy diet. 31% of patients were reported overweight. The present study reveals that most of the patients were found to have a high percentage of acne, hirsutism, and hair thinning; menstrual cycle irregularities such as oligomenorrhea and amenorrhea, which are clinical factors of hyperandrogenism; and 9.7% of females were found to have a positive family history of PCOS, which reveals genetic predisposition. This study also finds that 54.1% of females with infertility and 18.7% of females with miscarriage, which are complications of PCOS, if the disease is untreated or neglected.
References
2. Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107–2111
3. Bil E, Dilbaz B, Cirik DA, Ozelci R, Ozkaya E, Dilbaz S. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype. J. Obstet. Gynaecol. Res. 2016;42:837–843
4. Cohen S, Kamarck T, Mermelstein R.. A global measure of perceived stress. J Health Soc Behav. 1983; 24(4):385–396
5. Ebernella SD, Olexandra K, Crystal C, Mara S. Diagnosis and management of polycystic ovarian syndrome. CMAJ. 2024; 196(3):E85–E94.
6. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447
7. Garimna S, Shalini G, Vanita S, Naresh S, Seema Ch. Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene. Indian J Endocrinol Metab. 2019; 23(3):326–33.
8. Gul S, Zahid SA, Ansari A. PCOS: Symptoms and Awareness in Urban Pakistani Women. IJPRHS. 2014;2:356–60.
9. Ipsita M, Subha RS. BMI and Polycystic Ovary Syndrome: Demographic Trends in Weight and Health. Cureus. 2024; 3;16(3):e55439
10. Jiby JB, Mahesh KK, Naveen P, Teena K , Radha V, Karthikeyan R, Maruthy KN, Padmavathi R. Stress and polycystic ovarian syndrome-a case control study among Indian women. Clinical Epidemiology and Global Health. 2023; 22: 101326
11. Kheirollahi A, Hamidi H, Ankam V. Distribution of polycystic ovary syndrome (PCOS) phenotypes in Iranian women: a cross-sectional study. BMC Res Notes. 2025; 18: 215.
12. Kinda B, Abdul HR, Jamal K. Prevalence of Polycystic Ovary Syndrome in Women with Acne Vulgaris. Asian Journal of Research in Dermatological Science. 2020; 3(1): 5-13
13. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2013;98(12):4565–92
14. Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18:618–637
15. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106:6–15
16. Monroe SM. Modern approaches to conceptualizing and measuring human life stress. Annu Rev Clin Psychol. 2008; 4:33–52
17. Moran LJ, March WA, Whitrow MJ, Giles LC, Davies MJ, Moore VM. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum Reprod. 2015;30(2):466–472
18. Sonya P, Brianna DS, Laura JB, BS1, Margaret Lippincott, MD2,3, Maryanne M. Senna, MD. Polycystic ovarian syndrome in patients with hair thinning. J Am Acad Dermatol. 2020; 83(1): 260–261.
19. Stein IF, Leventhal MI. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–191
20. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin. Endocrinol. 2018;3:251–268
21. Unfer V, Kandakari E et al. When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments. Endocrine and Metabolic Science. 2024; 14: 100159
22. Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Reviews in Endocrine and Metabolic Disorders. Rev Endocr Metab Disord. 2007; 8: 331-342.

